InhaleRx (ASX:IRX) Total Long-Term Liabilities : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. InhaleRx's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was A$0.00 Mil.

InhaleRx Total Long-Term Liabilities Historical Data

The historical data trend for InhaleRx's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Total Long-Term Liabilities Chart

InhaleRx Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

InhaleRx Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Long-Term Liabilities	Get a 7-Day Free Trial												-	-	-	-	-

InhaleRx Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

InhaleRx Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of InhaleRx's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InhaleRx Ltd (ASX:IRX) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/- Prime Company Compliance, 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000

Website

https://www.inhalerx.com.au

InhaleRx Ltd is an Australian biotechnology company specialising in precision medicine delivered through inhalation. Its novel drug device combinations target the treatment of BTcP and PD to help improve the quality of life of sufferers of these diseases. The medications are being developed to be delivered via a pressurised metered dose inhaler (pMDI) in a fixed dose, providing a convenient and effective mode of administration. The company's clinical pipeline comprises IRX211, a THC-based synthetic cannabinoid derived drug (dronabinol) delivered via a pMDI in a fixed dose designed to provide rapid onset analgesia for patients suffering from acute episodic bursts of breakthrough pain; and IRX616a, for the treatment of panic disorders.

InhaleRx Headlines

No Headlines